Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

Merck KGaA May Withdraw Research from Portugal over Debt-Report

07/09/2012 | 02:28am US/Eastern

German chemical company Merck KGaA (>> Merck KGaA) may withdraw future investments for research projects in Portugal worth tens of millions of euros unless the government hospitals stick to the agreed-upon debt repayments, German daily newspaper Financial Times Deutschland reports Monday.

Merck Portugal's manager Fritz Sacher told the paper the company's research projects are long-term and require mutual trust as a basis. "The Portuguese government's lacking payment habits undermine this trust," he is quoted as saying.

Portuguese government hospitals owe the pharmaceutical industry a total of more than 1.5 billion euros ($1.84 billion) and companies have to wait nearly 550 days on average until invoices are paid, FTD reports.

Some companies, including Roche Holding AG (ROG.VX), have already halted the sale of medications on credit to highly indebted countries like Portugal, Greece, Spain and Italy until outstanding debts are paid, the paper notes, but for many companies such drastic steps are difficult as they carry responsibility for people's wellbeing.

Withdrawing research projects is a way of putting pressure on the government, as Portugal is an attractive location for research investments, FTD says. "The conditions for certain research and human studies are as good as in the U.S., but it's significantly more cost-effective in Portugal," Sacher told the paper.

Newspaper website:

Write to the Frankfurt Bureau at

Stocks mentioned in the article : Merck KGaA
Recommend :
React to this article
Latest news on MERCK KGAA
4d ago MERCK KGAA : EMD Serono to Take Part in Merck's Global Grants Initiative
5d ago MERCK KGAA : Biopharmaceutical Division Appoints Luciano Rossetti as EVP and Glo..
6d ago MERCK KGAA : Trademark Application for "ACAROID" Filed by Merck KGaA
6d ago MERCK KGAA : EMD Serono Participates in Global Grants Program to Fund Scientific..
6d ago MERCK KGAA : Serono Announces Global Grants Program to Fund Scientific Innovatio..
6d ago MERCK KGAA : Completes Squeeze-Out of AZ Electronic Materials
6d ago MERCK KGAA : Serono Appoints Luciano Rossetti as Global Head of R&D
07/14 MERCK KGAA : Biopharmaceutical Division Appoints Luciano Rossetti as Global Head..
07/12 MERCK KGAA : pharma chief says looking at mid-size deals - paper
07/11 MERCK KGAA : EMD Millipore Assigned Patent
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Income Statement Evolution
Merck KGaA : Income Statement Evolution
More Financials
Dynamic quotes